New Hampshire man is second person known to be living with a pig kidney [Globe and Mail, The (Toronto, Canada)]
United Therapeutics Corporation (UTHR)
Last united therapeutics corporation earnings: 4/29 06:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.unither.com/investor-relations
Company Research
Source: Globe and Mail, The
A New Hampshire man fought for the chance at a pig kidney transplant, spending months getting into good enough shape to be part of a small pilot study of a highly experimental treatment. His effort paid off: Tim Andrews, 66, is only the second person known to be living with a pig kidney. Andrews is free from dialysis, Massachusetts General Hospital announced Friday, and recovering so well from the Jan. 25 transplant that he left the hospital a week later. “When I woke up in the recovery room, I was a new man,” Andrews told the Associated Press. Andrews' surgery comes at a turning point in the quest to tell if animal-to-human transplants could help ease the shortage of donated human organs. The first four pig organ transplants – two hearts and two kidneys – were short-lived. But the fifth xenotransplant recipient, an Alabama woman not nearly as sick as prior patients, boosted the field – thriving for now 2½ months after a pig kidney transplant at NYU Langone Health in November.
Show less
Read more
Impact Snapshot
Event Time:
UTHR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
UTHR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
UTHR alerts
High impacting United Therapeutics Corporation news events
Weekly update
A roundup of the hottest topics
UTHR
News
- United Therapeutics (NASDAQ:UTHR) had its "buy (b-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- United Therapeutics Stock, Up 72% Since August, Nears Buy Point Of Rare Base [Yahoo! Finance]Yahoo! Finance
- United Therapeutics: Growing Company With Great Franchise In Pulmonary Diseases [Seeking Alpha]Seeking Alpha
- United Therapeutics (NASDAQ:UTHR) had its "buy (b-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- United Therapeutics (NASDAQ:UTHR) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..MarketBeat
UTHR
Earnings
- 10/29/25 - Beat
UTHR
Sec Filings
- 12/19/25 - Form 144
- 12/19/25 - Form 4
- 12/19/25 - Form 4
- UTHR's page on the SEC website